E.coli-derived human TTLL10 recombinant protein (Position: S205-P658). Human TTLL10 shares 65.4% and 64.9% amino acid (aa) sequence identity with mouse and rat TTLL10, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
Inactive polyglycylase TTLL10
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted